Header cover image

Belgian (BEL20) Healthcare Sector Analysis

UpdatedMay 27, 2024
DataAggregated Company Financials
Companies13
  • 7D1.2%
  • 3M9.8%
  • 1Y16.8%
  • YTD25.3%

The Healthcare industry is up 1.2% in the last week, with UCB up 3.0%. In the last 12 months, the industry was up 17%. Earnings are forecast to grow by 41% annually.

Sector Valuation and Performance

Has the Belgian Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 27 May 2024€51.6b€8.9b€38.0m50.4x1358.9x5.8x
Wed, 24 Apr 2024€50.7b€8.8b€59.6m46.7x850.2x5.8x
Fri, 22 Mar 2024€50.0b€8.7b€41.3m46.3x1211.3x5.7x
Sun, 18 Feb 2024€45.9b€9.1b-€84,041,777.7041.3x-545.7x5x
Tue, 16 Jan 2024€42.2b€9.1b-€124,647,133.0039.2x-338.9x4.6x
Thu, 14 Dec 2023€45.3b€9.1b-€128,254,460.0035.9x-352.9x5x
Sat, 11 Nov 2023€44.5b€9.2b-€145,418,820.0030.5x-306.2x4.9x
Mon, 09 Oct 2023€47.7b€9.0b-€302,630,135.0033.8x-157.7x5.3x
Wed, 06 Sep 2023€49.3b€9.0b-€356,540,037.0034.6x-138.3x5.5x
Fri, 04 Aug 2023€47.8b€9.0b-€330,722,615.0040.5x-144.4x5.3x
Sun, 02 Jul 2023€41.2b€9.1b-€350,320,609.0036.9x-117.6x4.5x
Tue, 30 May 2023€42.9b€9.1b-€359,763,687.0037.5x-119.2x4.7x
Thu, 27 Apr 2023€42.0b€8.9b-€263,953,119.0028x-159.2x4.7x
Sat, 25 Mar 2023€39.8b€8.9b-€286,278,884.0025.7x-139.1x4.5x
Mon, 20 Feb 2023€40.3b€9.1b€140.3m16.1x287.4x4.4x
Wed, 18 Jan 2023€42.3b€9.0b€126.1m16x335.9x4.7x
Fri, 16 Dec 2022€40.7b€9.0b€112.4m14.5x362.5x4.5x
Sun, 13 Nov 2022€39.4b€9.0b€86.8m14.4x453.8x4.4x
Tue, 11 Oct 2022€39.7b€8.9b€40.1m14.3x992x4.5x
Thu, 08 Sep 2022€40.3b€8.8b€66.9m14.2x601.7x4.6x
Sat, 06 Aug 2022€40.5b€8.8b€183.2m15.2x221.1x4.6x
Mon, 04 Jul 2022€42.4b€8.9b€602.3m16.4x70.5x4.8x
Wed, 01 Jun 2022€38.4b€8.9b€655.4m17.2x58.7x4.3x
Fri, 29 Apr 2022€43.8b€9.0b€841.5m20.5x52.1x4.9x
Sun, 27 Mar 2022€42.9b€9.0b€839.5m19.6x51.1x4.8x
Tue, 22 Feb 2022€36.8b€8.7b€744.2m14.9x49.5x4.3x
Thu, 20 Jan 2022€38.8b€8.6b€738.7m15.1x52.5x4.5x
Sat, 18 Dec 2021€41.0b€8.6b€736.1m15x55.6x4.7x
Mon, 15 Nov 2021€42.8b€8.6b€744.0m16.3x57.5x5x
Wed, 13 Oct 2021€40.2b€8.6b€755.7m15.9x53.2x4.7x
Fri, 10 Sep 2021€40.4b€8.6b€797.3m12.6x50.7x4.7x
Sun, 08 Aug 2021€36.3b€8.6b€461.9m18.9x78.5x4.2x
Price to Earnings Ratio

314.3x


Total Market Cap: €31.1bTotal Earnings: €98.8mTotal Revenue: €8.2bTotal Market Cap vs Earnings and Revenue0%0%0%
Belgian Healthcare Sector Price to Earnings3Y Average 126.7x202220232024
Current Industry PE
  • Investors are optimistic on the Belgian Healthcare industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 1kx which is higher than its 3-year average PE of 126x.
  • The 3-year average PS ratio of 4.8x is lower than the industry's current PS ratio of 5.8x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 27% per year over the last three years.
  • Meanwhile revenues for these companies have grown 2.8% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Belgian Healthcare sector?

BE Market-1.39%
Healthcare1.21%
Pharma2.99%
Life Sciences0%
Biotech-0.64%
Healthcare Services-2.13%
Healthtech-3.89%
Medical Equipment-6.67%
Industry PE
  • Investors are most optimistic about the Pharma industry which is trading above its 3-year average PE ratio of 31.0x.
    • Analysts are expecting annual earnings growth of 27.7%, which is higher than its past year's earnings decline of 7.4% per year.
Forecasted Growth
  • Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 103% over the next 5 years.
  • In contrast, the Healthcare Services industry is expected to see its earnings grow by 12% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
UCB UCB€128.501.4%
+€341.6m
55.6%PE71.1x
ARGX argenx€337.700.9%
+€184.2m
-10.0%PS15x
TUB Financière de Tubize€99.802.1%
+€93.5m
38.0%PE50.4x
NYXH Nyxoah€8.10-12.0%
€12.0m
14.7%PS53.8x
ONWD Onward Medical€5.205.7%
+€9.7m
-8.5%PS338.5x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

NYXH

€8.10

Nyxoah

7D

-12.0%

1Y

14.7%

FAGR

€18.38

Fagron

7D

-2.6%

1Y

6.3%

BIOS

€0.03

BioSenic

7D

79.4%

1Y

-76.7%

ARGX

€337.70

argenx

7D

0.9%

1Y

-10.0%

AGFB

€1.09

Agfa-Gevaert

7D

-3.9%

1Y

-57.8%

ONWD

€5.20

Onward Medical

7D

5.7%

1Y

-8.5%

MDXH

€3.02

MDxHealth

7D

-5.6%

1Y

-52.3%

UCB

€128.50

UCB

7D

1.4%

1Y

55.6%

IBAB

€13.60

Ion Beam Applications

7D

-6.1%

1Y

-11.7%

TUB

€99.80

Financière de Tubize

7D

2.1%

1Y

38.0%

SEQUA

€1.58

Sequana Medical

7D

-8.4%

1Y

-51.5%

ALIMG

€0.022

DMS Imaging

7D

-2.7%

1Y

7.3%

CYAD

€0.30

Celyad Oncology

7D

-5.5%

1Y

-44.4%